Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

22:37:17 Europe / Stockholm

Svenska | English

BioStock

WntResearch's CEO to BioStock: "If the effect is confirmed, there are good opportunities for licensing agreements next year"

2024-05-08 08:15:00

In the Q1 report, Per Norlén writes his first CEO statement for WntResearch since taking office in March. The company's focus right now is on the NeoFox study where recruitment is in full swing.
- We will put most of our focus on patient recruitment and business development in the near future, says Per in a comment to BioStock.

Read the full article at biostock.se (https://www.biostock.se/en/):

https://www.biostock.se/en/2024/05/wntresearchs-ceo-if-the-effect-is-confirmed-there-are-good-opportunities-for-licensing-agreements-next-year/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

BioStock

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden